Skip to main content

Aims and scope

Aims and scope

BMC Rheumatology is an open access, peer-reviewed journal that considers pre-clinical, translational and clinical articles on all aspects of the prevention, treatment and management of rheumatological diseases, related systemic and inflammatory conditions and associated comorbidities, as well as epidemiology, education, pathophysiology, genetics, and drug development.   

BMC Rheumatology does not make editorial decisions on the basis of the interest of a study or its likely impact. Studies must be scientifically valid; for research articles this includes a scientifically sound research question, the use of suitable methods and analysis, and following community-agreed standards relevant to the research field. Specific criteria for other article types can be found in the submission guidelines.

Annual Journal Metrics

  • Citation Impact
    4.000 - CiteScore
    0.980 - SNIP (Source Normalized Impact per Paper)
    0.886 - SJR (SCImago Journal Rank)

    Speed
    42 days to first decision for all manuscripts (Median)
    64 days to first decision for reviewed manuscripts only (Median)

    Usage 
    188,953 downloads (2021)
    265 Altmetric mentions (2021)

    Transparency and Openess
    TOP Factor Score - 8

Peer-review Terminology

  • The following summary describes the peer review process for this journal:

    Identity transparency: Single anonymized

    Reviewer interacts with: Editor

    Review information published: Review reports. Reviewer Identities reviewer opt in. Author/reviewer communication

    More information is available here

Sign up for article alerts and news from this journal